Search - tctmd.com

Displaying 61 - 80 of 127

Sort: Relevancy | Date

News Daily News

Calculator Developed to Predict AKI Risk After Angiography in VA Population

Caitlin E. Cox

December 29, 2015

News Daily News

血流动力学指导的补液可减少肾病和心衰患者的造影剂肾病

Todd Neale

December 09, 2015

News Daily News

Hemodynamic Guidance of Hydration Cuts Contrast Nephropathy in Patients With Kidney Disease, Heart Failure

Todd Neale

December 09, 2015

News Daily News

El Guiado Hemodinámico de la Hidratación Reduce la Nefropatía por Contraste en Pacientes con Enfermedad Renal, Insuficiencia Cardíaca

Todd Neale

December 09, 2015

Presentation

Prevention of Contrast-Induced Nephropathy by Central Venous Pressure (CVP)-Guided Fluid Administration

Presenter: G. Qian

December 08, 2015

News Daily News

肾病患者中心血管干预的数据有限，导致医生难以照料这一易感人群。

Michael O'Riordan

December 03, 2015

News Daily News

More Than Half of CVD Studies Exclude Patients With Kidney Disease

Michael O'Riordan

December 03, 2015

News Daily News

Más de la Mitad de los Estudios sobre ECV Excluyen a Pacientes con Enfermedad Renal

Michael O'Riordan

December 03, 2015

Presentation

Representation of Patients With Kidney Disease in Trials of CVD Interventions

Presenter: Ioannis Konstantinidis

December 02, 2015

News Daily News

血流动力学抑制与肾脏疾病患者行 CAS 后的肾损伤相关

L.A. McKeown

September 28, 2015

News Daily News

La Depresión Hemodinámica se asoció a la Lesión Renal Post-CAS en Pacientes con Enfermedad Renal

L.A. McKeown

September 28, 2015

News Daily News

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

L.A. McKeown

September 28, 2015

Presentation

AKI in Patients With Chronic Kidney Disease Undergoing Internal CAS Implantation

Presenter: M. Donahue

September 25, 2015

News Daily News

RenalGuard 防止 TAVR 患者发生 AKI 的效果优于生理盐水

September 22, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Daily News

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

September 22, 2015

Presentation

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

Presenter: Marco Barbanti

September 21, 2015

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Daily News

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

Yael L. Maxwell

July 15, 2015

Advertisement

Calculator Developed to Predict AKI Risk After Angiography in VA Population

血流动力学指导的补液可减少肾病和心衰患者的造影剂肾病

Hemodynamic Guidance of Hydration Cuts Contrast Nephropathy in Patients With Kidney Disease, Heart Failure

El Guiado Hemodinámico de la Hidratación Reduce la Nefropatía por Contraste en Pacientes con Enfermedad Renal, Insuficiencia Cardíaca

Prevention of Contrast-Induced Nephropathy by Central Venous Pressure (CVP)-Guided Fluid Administration

肾病患者中心血管干预的数据有限，导致医生难以照料这一易感人群。

More Than Half of CVD Studies Exclude Patients With Kidney Disease

Más de la Mitad de los Estudios sobre ECV Excluyen a Pacientes con Enfermedad Renal

Representation of Patients With Kidney Disease in Trials of CVD Interventions

血流动力学抑制与肾脏疾病患者行 CAS 后的肾损伤相关

La Depresión Hemodinámica se asoció a la Lesión Renal Post-CAS en Pacientes con Enfermedad Renal

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

AKI in Patients With Chronic Kidney Disease Undergoing Internal CAS Implantation

RenalGuard 防止 TAVR 患者发生 AKI 的效果优于生理盐水

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content